Chemoinformaics analysis of (E)-UNDEC-2-EN-1-OL
| Molecular Weight | 170.296 | nRot | 8 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 0 |
| Exact Molecular Weight | 170.167 | nRing | 0 |
| Solubility: LogS | -3.923 | nHRing | 0 |
| Solubility: LogP | 3.997 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 33.8414 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.5 |
| Synth | 2.469 |
| Natural Product Likeliness | 0.164 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.014 |
| CACO-2 | -4.288 |
| MDCK | 0.0000193 |
| BBB | 0.98 |
| PPB | 0.910992 |
| VDSS | 2.345 |
| FU | 0.177036 |
| CYP1A2-inh | 0.617 |
| CYP1A2-sub | 0.921 |
| CYP2c19-inh | 0.362 |
| CYP2c19-sub | 0.932 |
| CYP2c9-inh | 0.115 |
| CYP2c9-sub | 0.92 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.878 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.213 |
| CL | 7.552 |
| T12 | 0.397 |
| hERG | 0.057 |
| Ames | 0.011 |
| ROA | 0.263 |
| SkinSen | 0.293 |
| Carcinogencity | 0.264 |
| EI | 0.986 |
| Respiratory | 0.795 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.746363 |